A study focused on ovarian cancer, for instance, unveiled a significant increase in both CD68 + TAMs and CD163 + TAMs density in advanced ovarian cancer, with CD163 + TAM infiltration being associated with an adverse prognosis in ovarian cancer patients [19]. This evidence concerns the gene CD163 and ovarian cancer.